Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Laje P et al. - Despite a wide variety of potential adverse reactions, octreotide is generally well tolerated. It has been extensively demonstrated that octreotide reduces the splanchnic blood flow in a dose-dependent manner, affecting the entire gastrointestinal tract, and some concern has been recently raised regarding the potential implications of this effect in the development of necrotizing enterocolitis in neonates receiving octreotide for the management of congenital hyperinsulinism.


Today in Diabetes...keeping you current

Hemoglobin A1C and diabetes diagnosis: The Rancho Bernardo Study
Diabetes Care, 10/28/09

Carbohydrate-restricted diets for obesity and related diseases: An update
Current Atherosclerosis Reports, 11/17/09

Effects of Walnut Consumption on Endothelial Function in Type 2 Diabetics: A Randomized, Controlled, Cross-Over Trial
Diabetes Care, 11/04/09

Today in Pediatric Endocrinology...keeping you current

A Pilot Trial of Pramlintide Home Usage in Adolescents With Type 1 Diabetes
Pediatrics, 11/09/09

Radioactive iodine for hyperthyroidism in children and adolescents: referral rate and response to treatment
Clinical Endocrinology, 11/18/09

Paediatric diabetic ketoacidosis
Continuing Education in Anaesthesia, Critical Care & Pain , 11/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address